Urinary isoflavonoids and risk of type 2 diabetes: A prospective investigation in US women

British Journal of Nutrition

Volumn 114, Issue 10, 2015, Pages 1694-1701

  Ding, Ming ^a   Franke, Adrian A ^b   Rosner, Bernard A ^a,c   Giovannucci, Edward ^a,c   Van Dam, Rob M ^a,d   Tworoger, Shelley S ^a,c   Hu, Frank B ^a,c   Sun, Qi ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF HAWAII AT MANOA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Diabetes; Isoflavones; Menopausal status; Nested case control studies

Indexed keywords

DAIDZEIN; DIHYDRODAIDZEIN; DIHYDROGENISTEIN; GENISTEIN; ISOFLAVONOID; O DESMETHYLANGOLENSIN; UNCLASSIFIED DRUG; ISOFLAVONE DERIVATIVE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; TREND STUDY; URINALYSIS; URINARY EXCRETION; DIET; ESTROGEN THERAPY; MIDDLE AGED; NURSE; URINE; WOMEN'S HEALTH;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MIDDLE AGED; NURSES; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; WOMEN'S HEALTH;

EID: 84945484168     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515003359     Document Type: Article

References (44)

1. International Diabetes Federation (2013) International Diabetes Federation. IDF Diabetes Atlas, 6th ed. Brussels, Belgium: International Diabetes Federation.
2. Hu FB, Manson JE, Stampfer MJ, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345, 790-797.
3. Fung TT, Schulze M, Manson JE, et al. (2004) Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med 164, 2235-2240.
4. Van Dam RM, Rimm EB, Willett WC, et al. (2002) Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 136, 201-209.
5. Mozaffarian D, Hao T, Rimm EB, et al. (2011) Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364, 2392-2404.
6. Heianza Y, Arase Y, Kodama S, et al. (2013) Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care 36, 4007-4014.
7. Szmuilowicz ED, Stuenkel CA & Seely EW (2009) Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 5, 553-558.
8. Cho GJ, Lee JH, Park HT, et al. (2008) Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 15, 524-529.
9. Kanaya AM, Herrington D, Vittinghoff E, et al. (2003) Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. A randomized, doubleblind, placebo-controlled trial. Ann Intern Med 138, 1-9.
10. Manson JE, Chlebowski RT, Stefanick ML, et al. (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. J Am Med Assoc 310, 1353-1368.
11. Manson JE, Rimm EB, Colditz GA, et al. (1992) A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol 2, 665-673.
12. Rossi R, Origliani G & Modena MG (2004) Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women. Diabetes Care 27, 645-649.
13. Liu ZM, Chen YM & Ho SC (2011) Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 93, 1092-1101.
14. Yang B, Chen Y, Xu T, et al. (2011) Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr 20, 593-602.
15. Mueller NT, Odegaard AO, Gross MD, et al. (2012) Soy intake and risk of type 2 diabetes in Chinese Singaporeans [corrected]. Eur J Nutr 51, 1033-1040.
16. Nanri A, Mizoue T, Takahashi Y, et al. (2010) Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr 140, 580-586.
17. Zamora-Ros R, Forouhi NG, Sharp SJ, et al. (2013) The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: The EPIC-InterAct study. Diabetes Care 36, 3961-3970.
18. Bhagwat S, Haytowitz DB & Holden JM (2008) USDA database for the isoflavone content of selected foods release 2.0.
19. Spencer JP, Abd El Mohsen MM, Minihane AM, et al. (2008) Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99, 12-22.
20. Zamora-Ros R, Touillaud M, Rothwell JA, et al. (2014) Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits. Am J Clin Nutr 100, 11-26.
21. Franke AA, Custer LJ, Wilkens LR, et al. (2002) Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777, 45-59.
22. Perez-Jimenez J, Hubert J, Hooper L, et al. (2010) Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. Am J Clin Nutr 92, 801-809.
23. Muthyala RS, Ju YH, Sheng S, et al. (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 12, 1559-1567.
24. Seow A, Shi CY, Franke AA, et al. (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7, 135-140.
25. Maskarinec G, Singh S, Meng L, et al. (1998) Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7, 613-619.
26. Prentice RL & Breslow NE (1978) Retrospective studies and failure time models. Biometrika 65, 153-158.
27. Manson JE, Rimm EB, Stampfer MJ, et al. (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338, 774-778.
28. Willett WC (1998) Nutritional Epidemiology, 2nd ed. New York: Oxford University Press.
29. McCullough ML & Willett WC (2006) Evaluating adherence to recommended diets in adults: The Alternate Healthy Eating Index. Public Health Nutr 9, 152-157.
30. Chiuve SE, Fung TT, Rimm EB, et al. (2012) Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 142, 1009-1018.
31. Franke AA, Halm BM, Kakazu K, et al. (2009) Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test Anal 1, 14-21.
32. Messina MJ & Wood CE (2008) Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 7, 17.
33. Ricci E, Cipriani S, Chiaffarino F, et al. (2010) Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: A meta-analysis of randomized controlled trials. Menopause 17, 1080-1086.
34. Golditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90, 814-823.
35. Maccio A & Madeddu C (2011) Obesity, inflammation, and postmenopausal breast cancer: Therapeutic implications. Sci World J 11, 2020-2036.
36. Mezei O, Banz WJ, Steger RW, et al. (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133, 1238-1243.
37. Kim S, Sohn I, Ahn JI, et al. (2004) Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 340, 99-109.
38. Mezei O, Li Y, Mullen E, et al. (2006) Dietary isoflavone supplementation modulates lipid metabolism via PPARalphadependent and-independent mechanisms. Physiol Genomics 26, 8-14.
39. Cederroth CR, Vinciguerra M, Gjinovci A, et al. (2008) Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57, 1176-1185.
40. Babu PV, Liu D & Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 24, 1777-1789.
41. Villegas R, Gao YT, Yang G, et al. (2008) Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 87, 162-167.
42. Morimoto Y, Steinbrecher A, Kolonel LN, et al. (2011) Soy consumption is not protective against diabetes in Hawaii: The Multiethnic Cohort. Eur J Clin Nutr 65, 279-282.
43. Struja T, Richard A, Linseisen J, et al. (2014) The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES. Eur J Nutr 53, 1371-1381.
44. Rowland IR, Wiseman H, Sanders TA, et al. (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27-32.